DaVita Inc
DVA141.510USD
+1.009+0.72%
Close 04/29, 16:00（ET）Quotes delayed by 15 min
11.40BMarket Cap
12.17P/E TTM
More Details of DaVita Inc Company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
Company codeDVA
Company nameDaVita Inc
IPO dateOct 31, 1995
Founded at1994
CEOMr. Javier J. Rodriguez
Number of employees76000
Security typeOrdinary Share
Fiscal year-endOct 31
Address2000 16th St
CityDENVER
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code80202-5117
Phone13105362668
Websitehttps://www.davita.com/
Company codeDVA
IPO dateOct 31, 1995
Founded at1994
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Mr. Charles G. (Chuck) Berg, J.D.
Mr. Charles G. (Chuck) Berg, J.D.
Independent Director
Independent Director
26.68K
+1.33%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.23K
+1.40%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
16.63K
+38.27%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
12.85K
+2.79%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
12.31K
-27.55%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Mr. Charles G. (Chuck) Berg, J.D.
Mr. Charles G. (Chuck) Berg, J.D.
Independent Director
Independent Director
26.68K
+1.33%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.23K
+1.40%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
6.37B
49.74%
Patient service - Commercial
4.03B
31.46%
Patient service - Other government
1.06B
8.28%
Patient service - Medicaid and Managed Medicaid
863.95M
6.74%
Other - Medicare and Medicare Advantage
463.73M
3.62%
Other
19.70M
0.15%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Patient service - Medicare and Medicare Advantage
6.37B
49.74%
Patient service - Commercial
4.03B
31.46%
Patient service - Other government
1.06B
8.28%
Patient service - Medicaid and Managed Medicaid
863.95M
6.74%
Other - Medicare and Medicare Advantage
463.73M
3.62%
Other
19.70M
0.15%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Berkshire Hathaway Inc.
45.72%
The Vanguard Group, Inc.
6.76%
BlackRock Institutional Trust Company, N.A.
3.80%
State Street Global Advisors (US)
3.05%
Weschler (R Ted)
2.84%
Other
37.84%
Shareholder Statistics
Shareholder
Proportion
Berkshire Hathaway Inc.
45.72%
The Vanguard Group, Inc.
6.76%
BlackRock Institutional Trust Company, N.A.
3.80%
State Street Global Advisors (US)
3.05%
Weschler (R Ted)
2.84%
Other
37.84%
Type
Shareholder
Proportion
Holding Company
45.73%
Investment Advisor
22.27%
Investment Advisor/Hedge Fund
21.39%
Individual Investor
4.65%
Hedge Fund
2.78%
Pension Fund
1.91%
Research Firm
1.63%
Bank and Trust
1.09%
Sovereign Wealth Fund
0.11%
Institutional Shareholding
Update time: Mon, Jan 20
Update time: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1238
78.42M
98.02%
-4.90M
2024Q4
1260
79.70M
99.28%
-3.76M
2024Q3
1214
80.97M
98.10%
-3.96M
2024Q2
1180
82.28M
96.62%
-4.32M
2024Q1
1166
84.15M
95.98%
-4.07M
2023Q4
1163
84.91M
95.56%
-3.04M
2023Q3
1159
85.40M
93.52%
-3.20M
2023Q2
1164
84.27M
92.30%
-4.64M
2023Q1
1168
84.01M
92.60%
-5.13M
2022Q4
1198
83.55M
92.31%
-8.33M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Berkshire Hathaway Inc.
35.14M
43.93%
-953.09K
-2.64%
Feb 19, 2025
The Vanguard Group, Inc.
5.19M
6.49%
-167.41K
-3.12%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
2.92M
3.65%
-212.41K
-6.79%
Dec 31, 2024
State Street Global Advisors (US)
2.34M
2.93%
-68.93K
-2.86%
Dec 31, 2024
Weschler (R Ted)
2.18M
2.73%
--
--
Aug 06, 2024
Invesco Capital Management LLC
1.24M
1.54%
+285.57K
+30.05%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.15M
1.44%
-14.40K
-1.24%
Dec 31, 2024
LSV Asset Management
1.03M
1.29%
-25.40K
-2.41%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
902.42K
1.13%
-76.86K
-7.85%
Dec 31, 2024
Rodriguez (Javier J)
894.08K
1.12%
+18.82K
+2.15%
Mar 15, 2025
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
Invesco Dorsey Wright Healthcare Momentum ETF
3.43%
Strategas Global Policy Opportunities ETF
2.15%
SPDR S&P Health Care Services ETF
2.14%
Aztlan Global Stock Selection DM SMID ETF
1.72%
First Trust Health Care Alphadex Fund
1.71%
Invesco S&P 500 Equal Weight Health Care ETF
1.51%
Pacer US Cash Cows Growth ETF
1.4%
LG QRAFT AI-Powered US Large Cap Core ETF
1.3%
LeaderShares AlphaFactor US Core ETF
1.26%
Global X Aging Population ETF
1.1%
View more
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion3.43%
Strategas Global Policy Opportunities ETF
Proportion2.15%
SPDR S&P Health Care Services ETF
Proportion2.14%
Aztlan Global Stock Selection DM SMID ETF
Proportion1.72%
First Trust Health Care Alphadex Fund
Proportion1.71%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.51%
Pacer US Cash Cows Growth ETF
Proportion1.4%
LG QRAFT AI-Powered US Large Cap Core ETF
Proportion1.3%
LeaderShares AlphaFactor US Core ETF
Proportion1.26%
Global X Aging Population ETF
Proportion1.1%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data